Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical combination comprising binimetinib

Pharmaceutical combination comprising binimetinib

US Patent 9867825 · Granted Jan 16, 2018

Estimated economic value: $9,480,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic combinations comprising a c-RAF inhibitor2024
High activity platinum and nickel yolk-shell catalysts2023
Direct synthesis of light olefins from carbon dioxide using yttria-stabilized zi2023
Combinations of MDM2 inhibitors with inhibitors of ERK for treating cancers2022
Pharmaceutical combinations2022
Therapeutic uses of a C-RAF inhibitor2021
Combination therapy2020
Pharmaceutical combinations2019
Pharmaceutical combination comprising the PI3K inhibitor alpelisib and the B-RAF2019
Pharmaceutical combination comprising the PI3K inhibitor alpelisib and the B-RAF2019
Pharmaceutical combination comprising the PI3K inhibitor alpelisib and the CDK4/2019
Pharmaceutical combination comprising the PI3K inhibitor alpelisib and the CDK4/2019